Steven Valiquette (Mizuho Securities) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Steven Valiquette's stock ratings?

About 57% of Steven's ratings were profitable over a one-year hold, with an average return of +1.6% per rating, measured by 13Foresight from historical prices.

Q: How is Steven ranked?

Steven Valiquette is ranked #1942 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Analyst Tracker/Steven Valiquette

MIZU

Steven Valiquette

Mizuho Securities

Wall Street Analyst

★★☆☆☆

#1942

on 13Foresight · ranked by our own returns

57%

Success Rate

+1.5%

Average Return

31 of 54 calls profitable · -12.0% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

📈 Across the calls we could measure, roughly 57% of Steven Valiquette's ratings turned a profit when each position was held for 1 year — averaging +1.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

36 Buy 31 Hold 2 Sell

Steven's Stock Coverage 55 ratings · 2026-06-18

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
VEEV Veeva Systems	Jun 03, 2026	BUY	Buy +53.3% avg upside 36 analysts	$270.00 74.45% Upside	-9.3%
DOCS Doximity	May 14, 2026	HOLD	Buy +61.4% avg upside 27 analysts	$26.00 27.24% Upside	+14.8%
HSIC Henry Schein	May 06, 2026	HOLD	Buy +7.3% avg upside 25 analysts	$82.00 2.51% Upside	+12.1%
XRAY DENTSPLY SIRONA	May 06, 2026	HOLD	Buy +177.1% avg upside 25 analysts	$14.00 39.50% Upside	-5.1%
ALGN Align Tech	Apr 30, 2026	BUY	Strong Buy +62.9% avg upside 21 analysts	$220.00 26.80% Upside	-1.4%
PHR Phreesia	Mar 24, 2026	BUY	Strong Buy +82.5% avg upside 21 analysts	$19.00 103.15% Upside	-22.2%
LFMD LifeMD	Mar 16, 2026	BUY	Strong Buy +139.5% avg upside 13 analysts	$8.00 62.98% Upside	-1.6%
GDRX GoodRx Holdings	Feb 27, 2026	HOLD	Buy +389.3% avg upside 28 analysts	$3.00 14.86% Upside	+41.7%
MDLN Medline	Feb 26, 2026	BUY	Strong Buy +41.3% avg upside 26 analysts	$53.00 45.47% Upside	-26.5%
TDOC Teladoc	Feb 26, 2026	HOLD	Buy +278.2% avg upside 37 analysts	$6.00 21.01% Downside	+32.5%
TALK Talkspace	Feb 20, 2026	BUY	Buy -13.0% avg upside 12 analysts	$6.00 15.45% Upside	+4.2%
CAH Cardinal Health	Feb 10, 2026	BUY	Strong Buy -13.9% avg upside 29 analysts	$235.00 3.93% Upside	+3.0%
MCK McKesson	Feb 10, 2026	HOLD	Strong Buy -4.5% avg upside 27 analysts	$885.00 13.49% Upside	-17.0%
NVST Envista Holdings	Feb 10, 2026	HOLD	Buy +16.9% avg upside 19 analysts	$27.00 8.60% Upside	-23.0%
WAY Waystar Holding Corp.	Feb 04, 2026	BUY	Strong Buy +108.2% avg upside 29 analysts	$42.00 130.07% Upside	-23.2%
SOLV Solventum Corporation	Jan 20, 2026	BUY	Buy +15.4% avg upside 15 analysts	$100.00 34.06% Upside	-5.6%
COR Cencora	Nov 06, 2025	BUY	Buy +13.1% avg upside 43 analysts	$380.00 37.05% Upside	-21.3%
HQY Healthequity	Jul 02, 2025	BUY	Strong Buy +32.2% avg upside 20 analysts	$126.00 46.02% Upside	-15.4%
HUM Humana	Aug 23, 2023	BUY	Buy -11.8% avg upside 34 analysts	$585.00 61.63% Upside	-26.1%
MPT Medical Properties Trust	Aug 21, 2023	BUY	Hold +154.0% avg upside 24 analysts	$10.00 110.97% Upside	·
CVS CVS Health	Aug 17, 2023	BUY	Strong Buy +2.5% avg upside 38 analysts	$86.00 13.27% Downside	-9.2%
SNDA Sonida Senior Living	Aug 14, 2023	SELL	Buy +158.8% avg upside 12 analysts	$5.00 85.57% Downside	-217.4%
HR Healthcare Realty Trust	Aug 10, 2023	BUY	Buy +7.9% avg upside 23 analysts	$24.00 19.79% Upside	+7.4%
SBRA Sabra Healthcare REIT	Aug 10, 2023	HOLD	Buy +7.1% avg upside 28 analysts	$13.00 27.94% Downside	+46.6%
BKD Brookdale Senior Living	Aug 10, 2023	BUY	Strong Buy +10.7% avg upside 11 analysts	$7.00 48.51% Downside	+61.0%
CTRE CareTrust REIT	Aug 08, 2023	HOLD	Strong Buy -0.1% avg upside 22 analysts	$20.00 45.09% Downside	+39.4%
ELV Elevance Health	Aug 08, 2023	BUY	Strong Buy +10.2% avg upside 32 analysts	$575.00 46.98% Upside	+15.2%
VTR Ventas	Aug 07, 2023	BUY	Strong Buy -0.1% avg upside 34 analysts	$55.00 32.96% Downside	+31.8%
OHI Omega Healthcare	Aug 04, 2023	HOLD	Buy -3.5% avg upside 29 analysts	$31.00 30.56% Downside	+29.1%
CI Cigna	Aug 03, 2023	BUY	Strong Buy +21.9% avg upside 29 analysts	$355.00 24.56% Upside	+19.3%
WELL Welltower	Aug 01, 2023	BUY	Strong Buy -11.8% avg upside 32 analysts	$92.00 55.54% Downside	+36.5%
THC Tenet Healthcare	Aug 01, 2023	BUY	Strong Buy +22.3% avg upside 26 analysts	$105.00 41.13% Downside	+92.7%
EHC Encompass Health	Jul 28, 2023	HOLD	Strong Buy +13.6% avg upside 22 analysts	$61.00 37.72% Downside	+39.8%
UHS Universal Health	Jul 27, 2023	HOLD	Buy +50.2% avg upside 22 analysts	$142.00 0.48% Upside	+55.6%
HCA HCA Healthcare	Jul 27, 2023	HOLD	Strong Buy +11.5% avg upside 35 analysts	$300.00 22.79% Downside	+29.5%
MOH Molina Healthcare	Jul 27, 2023	BUY	Buy +13.8% avg upside 25 analysts	$375.00 91.80% Upside	+9.1%
DOC Healthpeak Properties	Jul 25, 2023	BUY	Buy +18.4% avg upside 42 analysts	$32.00 64.99% Upside	+0.6%
UNH UnitedHealth	Jul 14, 2023	BUY	Strong Buy +2.5% avg upside 35 analysts	$565.00 41.47% Upside	+8.2%
CNC Centene	Jul 12, 2023	BUY	Buy +8.9% avg upside 28 analysts	$86.00 41.76% Upside	+6.4%
CTEV Claritev	Jun 29, 2023	HOLD	Strong Buy -2.7% avg upside 8 analysts	$2.00 93.27% Downside	-81.1%
LTC LTC Properties	May 03, 2023	SELL	Hold +3.4% avg upside 15 analysts	$34.00 5.70% Downside	-8.0%
GOCO GoHealth	Mar 02, 2022	HOLD	Hold +4154.1% avg upside 12 analysts	$30.00 9736.07% Upside	+18.8%
GOCOQ GoHealth	Mar 02, 2022	HOLD	Hold +4000.9% avg upside 6 analysts	$30.00	·
EHTH Ehealth	Mar 01, 2022	HOLD	Hold +874.5% avg upside 19 analysts	$16.00 869.79% Upside	-39.2%
SLQT SelectQuote	Feb 08, 2022	HOLD	Buy +676.8% avg upside 16 analysts	$5.00 400.95% Upside	-56.1%
AVAH Aveanna Healthcare Holdings	Aug 12, 2021	BUY	Buy +19.6% avg upside 17 analysts	$15.00 98.84% Upside	-78.6%
INNV InnovAge Holding	Aug 12, 2021	BUY	Sell -20.3% avg upside 12 analysts	$19.00 107.67% Upside	-72.2%
CYH Community Health	Aug 03, 2021	SELL	Sell +45.4% avg upside 18 analysts	$10.00 233.31% Upside	+73.8%
ACH Accendra Health	Feb 25, 2021	HOLD	Hold +449.1% avg upside 17 analysts	$33.00 944.31% Upside	+32.7%
DVA DaVita	Jan 15, 2021	BUY	Hold -23.8% avg upside 17 analysts	$135.00 35.83% Downside	-2.1%
RMAX Re/Max Holdings	Jun 30, 2017	SELL	Hold +160.5% avg upside 13 analysts	—	+5.1%
MDRX Veradigm	May 15, 2017	HOLD	Buy +207.0% avg upside 22 analysts	$14.00 191.60% Upside	+4.1%
DGX Quest Diagnostics	Mar 16, 2017	HOLD	Buy -13.1% avg upside 33 analysts	—	+7.6%
ICLR Icon	Sep 17, 2013	BUY	Strong Buy +26.2% avg upside 25 analysts	$50.00 65.05% Downside	+41.6%
CRL Charles River Labs	Sep 17, 2013	HOLD	Strong Buy +13.1% avg upside 34 analysts	$49.00 73.22% Downside	+27.9%

🔒 50 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Steven Valiquette — Frequently Asked Questions

How accurate are Steven Valiquette's stock ratings?

Based on the calls 13Foresight could measure, about 57% of Steven's ratings were profitable over a one-year hold, with an average return of +1.6% per rating, or -12.0% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Steven ranked on 13Foresight?

Steven Valiquette is currently ranked #1942 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Steven cover?

Steven most recently has ratings on VEEV, DOCS, HSIC, XRAY, ALGN, PHR, LFMD, GDRX, MDLN, TDOC, TALK, CAH and 43 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!